# Atalanta Therapeutics: portfolio, investments and team > Atalanta Therapeutics is a growth equity based in Japan. 8 investments on record, latest Dec 2024. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/atalanta-therapeutics (Millionrounds; every figure on the page links to its filing or article) Japan · [Investor](https://millionrounds.com/investors) # Atalanta Therapeutics Last cheque observed Dec 2024. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Growth equity Quiet Series A Series D Series B Biotechnology Life Science Follow Atalanta Therapeutics and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fatalanta-therapeutics) Cheques on record **0%** of best year **0** **cheques in 12 months**, 8 on record Since the last cheque **701** days **00** hrs **00** min **00** sec Median round **$60M** Rounds led **0 of 8** Sole investor **2 rounds** Exits **3 from the portfolio** Mostly in **United States, 57%** Pitch Atalanta Therapeutics ## Atalanta Therapeutics highlights - 01 8 rounds on record - 02 Mostly Series A and Series D: 80% of its rounds - 03 Sole investor in 2 rounds, median $7.0M - 04 3 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Biotechnology Life Science - **Based in:** Hook, Japan - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **8 appearances** - **2024** 1 round - **Dec** **[Heirloom](https://millionrounds.com/company/heirloom)** Series B · US · Crunchbase News **$150M** With 11 others - **2019** 2 rounds - **Nov** **[MaaS Global](https://millionrounds.com/company/maas-global)** FI · News **$60M** With 3 others - **Sept** **[Litmus Automation](https://millionrounds.com/company/litmus-automation)** Series A · US · FinSMEs **$7.0M** Sole investor - **2010** 1 round - **Jul** **[Cara Therapeutics](https://millionrounds.com/company/cara-therapeutics)** Series D · US · fiercebiotech.com **$15M** With 7 others - **2001** 1 round - **Jan** **[e-LogiT](https://millionrounds.com/company/e-logit)** JP **Undisclosed** Sole investor - **2000** 2 rounds - **Aug** **[Silicon Wave](https://millionrounds.com/company/silicon-wave)** Series D **$52M** With 15 others - **Mar** **[DeNA](https://millionrounds.com/company/dena)** Series A · JP · c-direct.ne.jp **$12M** With 2 others - **1999** 1 round - **Dec** **[Sonus Networks](https://millionrounds.com/company/sonus-networks)** US **$23M** With 9 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## Exits from the portfolio Companies it backed that were later bought or listed **3 in all** **[DeNA](https://millionrounds.com/company/dena)** Bought by peroli **Undisclosed** Oct 2014 **[DeNA](https://millionrounds.com/company/dena)** Listed **Undisclosed** Feb 2005 **[Silicon Wave](https://millionrounds.com/company/silicon-wave)** Bought by RFMD **Undisclosed** Apr 2004 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series A Series D Series B Median round joined **$60M** the round, not its cheque Alone, median **$7.0M** Led 0 of 8 rounds **0%** - **Sole investor:** 2 rounds - **Last cheque:** Dec 2024 - **Exits:** 3 from the portfolio Rounds by stage said on their site - Series A *2* - Series D *2* - Series B *1* Cheques by month Led Joined Dec 2023 Nov 2026 **Pitching Atalanta Therapeutics?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Recently backed The latest companies Atalanta Therapeutics put money into. [**Litmus Automation** $7.0M · Sept 2019](https://millionrounds.com/company/litmus-automation) ## Quick answers about Atalanta Therapeutics ### What does Atalanta Therapeutics invest in? Atalanta Therapeutics invests most often at Series A and Series D (80% of the rounds on record), in sectors such as Biotechnology and Life Science. ### How active is Atalanta Therapeutics? 8 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2024. ### What has Atalanta Therapeutics invested in recently? Its most recent investments on record: Heirloom (Series B, Dec 2024), MaaS Global (Undisclosed round, Nov 2019) and Litmus Automation (Series A, Sept 2019). ### How big are Atalanta Therapeutics's cheques? The median round it joins is $60M. ### Does Atalanta Therapeutics lead rounds? Rarely, if at all: none of its 8 investments on record names it as the lead. ### Where does Atalanta Therapeutics invest? Most of the companies it backs are in the United States (57%), Japan (29%) and Finland (14%). ### Is Atalanta Therapeutics investing now? No investments in the last 12 months; the latest was in Dec 2024. ### What kind of investor is Atalanta Therapeutics? Atalanta Therapeutics is a growth equity firm based in Hook, Japan. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=atalanta-therapeutics) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=atalanta-therapeutics)